Insider · CIK 0001576686
Shane Hostetter
cfoofficer
Files at CC (Chemours Co). First filing May 21, 2025, latest May 21, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$50k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CC: Chemours Co
CCOct 9, 2026 · close 13.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Chemours Co | $50k 4,450 shares | +8% | +18% from low-48% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | CC Chemours Co | FTax withholding Common Stock | -3,232 | $18.24 | $59k | 54,470 | Mar 3, 2026 |
| Mar 2, 2026 | CC Chemours Co | AGrant or award Common Stock | +47,387 | $0.00 | $0 | 101,857 | Mar 3, 2026 |
| Aug 6, 2025 | CC Chemours Co | FTax withholding Common Stock | -3,021 | $12.00 | $36k | 57,115 | Aug 8, 2025 |
| May 19, 2025 | CC Chemours Co | POpen-market purchase Common Stock | +4,450 | $11.28 | $50k | 59,694 | May 21, 2025 |
| Mar 3, 2025 | CC Chemours Co | AGrant or award Common Stock | +27,326 | $0.00 | $0 | 54,035 | Mar 5, 2025 |
| Mar 3, 2025 | CC Chemours Co | AGrant or award Stock Option (Right to Buy)derivative | +90,827 | $0.00 | $0 | 90,827 | Mar 5, 2025 |
| Mar 3, 2025 | CC Chemours Co | AGrant or award Stock Option (Right to Buy)derivative | +94,460 | $0.00 | $0 | 94,460 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.